Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W E So

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncogene|September 6, 2016
Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical developmentC T Tsai, C W E So
Leukemia|April 17, 2008
C/EBPalpha, do not forget your TIP60C W E So, B A van der Reijden
British Journal of Cancer|September 24, 2014
Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapiesM F Arteaga, J-H Mikesch, T-K Fung, et al.
Leukemia|August 5, 2006
The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric miceC T Kong, M H Sham, C W E So, et al.
Leukemia|December 17, 2014
Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemiaJ J Qiu, B B Zeisig, S Li, et al.
Leukemia|February 10, 2016
Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemiaJ R Lynch, H Yi, D A Casolari, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncogene|September 6, 2016
Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical developmentC T Tsai, C W E So
Leukemia|April 17, 2008
C/EBPalpha, do not forget your TIP60C W E So, B A van der Reijden
British Journal of Cancer|September 24, 2014
Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapiesM F Arteaga, J-H Mikesch, T-K Fung, et al.
Leukemia|August 5, 2006
The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric miceC T Kong, M H Sham, C W E So, et al.
Leukemia|December 17, 2014
Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemiaJ J Qiu, B B Zeisig, S Li, et al.
Leukemia|February 10, 2016
Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemiaJ R Lynch, H Yi, D A Casolari, et al.
Pageof 1